September 23, 2020
The director of the UCSF Weill Institute for Neuroscience spoke to the advantages of having agents that can be used across the spectrum of MS, and the role disease progression plays early on.
This new idea that progression in MS is present across the continuum [of disease], and is also more easily controlled earlier on, means that highly effective therapy as early as possible is a very reasonable clinical approach to patients.”
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews